I think if Jinka was not acquired we would have been 2-3c mid last year. The bottom would have fallen out of this stock. With production set at Burnakurra and more recently upgrades to Gab & Jervois I see the market has priced this in at another 7-9c. Since late 2011, I believe the market has added value with new confidence in Andash with another 2-3c.
All these are well below even a discounted NPV for the above projects. The market had re-rated (down) most stocks that were 100% speculative. I doubt that an announcement will re-rate this now, but once we are in production mid year we will see all our projects re valued closer to their NPV's.
Regardless, I believe 18c still a fair target on confirmation of the social license and extension of the permit which I believe will follow soon after.
BTW, great work Chuk!
- Forums
- ASX - By Stock
- KGL
- what is currently priced in?
what is currently priced in?, page-2
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
Add KGL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $61.57M |
Open | High | Low | Value | Volume |
9.5¢ | 10.0¢ | 9.5¢ | $16.87K | 172.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 202892 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 107074 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 202892 | 0.095 |
1 | 106000 | 0.094 |
2 | 105376 | 0.093 |
2 | 110761 | 0.092 |
2 | 176000 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 107074 | 2 |
0.105 | 25000 | 1 |
0.110 | 45864 | 3 |
0.115 | 100000 | 1 |
0.120 | 736648 | 6 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
KGL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online